Download Citation
Article Source:
Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis
Berger BA,
Cossio A,
Saravia NG,
Castro MdM,
Prada S,
et al.
(2017)
Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis.
PLOS Neglected Tropical Diseases 11(4): e0005459.
https://doi.org/10.1371/journal.pntd.0005459